Mots-clés
> MYOBASE > SOCIETE > démographie > épidémiologie > morbidité > prévalence
prévalence
Commentaire :
Nombre total de cas d'une maladie dans une population donnée pendant un temps déterminé, sans distinction entre cas anciens et nouveaux. (d'après le MeSH ; 10/08/2005)
|
Documents disponibles dans cette catégorie (707)
trié(s) par (Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de recherche
Etendre la recherche sur niveau(x) vers le bas
Article
Prior TW ; Leach ME ; Finanger E | 3/12/2020Initial Posting: February 24, 2000; Last Revision: December 3, 2020. Clinical characteristics. Spinal muscular atrophy (SMA) is characterized by muscle weakness and atrophy resulting from progressive degeneration and irreversible loss of t[...]Article
Fernandez-Eulate G, Auteur ; Leturcq F ; Laforet P ; Richard I ; Stojkovic T | AFM-TELETHON | Les cahiers de myologie | 12/2020Les sarcoglycanopathies font partie des dystrophies musculaires des ceintures (LGMD) autosomiques récessives et représentent la troisième cause la plus fréquente d’entre elles. Elles sont consécutives à un déficit d’un des sarcoglycanes α, β, γ,[...]Article
Trollet C ; Boulinguiez A ; Roth F ; Stojkovic T ; Butler Browne G ; Evangelista T ; Lacau St Guily J ; Richard P | 22/10/2020Initial Posting: March 8, 2001; Last Update: October 22, 2020. Clinical characteristics. Oculopharyngeal muscular dystrophy (OPMD) is characterized by ptosis and dysphagia due to selective involvement of the muscles of the eyelids and phar[...]Article
Initial Posting: April 2, 2009; Last Update: September 17, 2020. Clinical characteristics. Most individuals with classic GBE1 adult polyglucosan body disease (GBE1-APBD) present after age 40 years with unexplained progressive neurogenic bl[...]Article
Chrestian N | 27/08/2020Initial Posting: September 28, 1998; Last Update: August 27, 2020. Clinical characteristics. Hereditary neuropathy with liability to pressure palsies (HNPP) is characterized by recurrent acute sensory and motor neuropathy in a single or mu[...]Article
Update : 2020 August. (Last Update: March 19, 2023)Article
Ferreira C ; Pierre G ; Thompson R ; Vernon H | 09/07/2020nitial Posting: October 9, 2014; Last Update: July 9, 2020. Clinical characteristics. Barth syndrome is characterized in affected males by cardiomyopathy, neutropenia, skeletal myopathy, prepubertal growth delay, and distinctive facial ges[...]Article
Article
Article
Rivner MH ; Quarles BM ; Pan JX ; Yu Z ; Howard Jr JF ; Corse A ; Dimachkie MM ; Jackson C ; Vu T ; Small G ; Lisak RP ; Belsh J ; Lee I ; Nowak RJ ; Baute V ; Scelsa S ; Fernandes JA ; Simmons Z ; Swenson A ; Barohn R ; Sanka RB ; Gooch C ; Ubogu E ; Caress J ; Pasnoor M ; Xu H ; Mei L | United States | 06/2020Article
Zuchner S | 14/05/2020Initial Posting: February 18, 2005; Last Update: May 14, 2020. Clinical characteristics. MFN2 hereditary motor and sensory neuropathy (MFN2-HMSN) is a classic axonal peripheral sensorimotor neuropathy, inherited in either an autosomal domi[...]Article
Mah ML ; Cripe L ; Slawinski MK ; Al Zaidy SA ; Camino E ; Lehman KJ ; Jackson JL ; Iammarino M ; Miller N ; Mendell JR ; Hor KN | Netherlands | 05/2020Article
Carrillo N ; Malicdan MC ; Huizing M | 09/04/2020Initial Posting: March 26, 2004; Last Update: April 9, 2020. Clinical characteristics. GNE myopathy is a slowly progressive muscle disease that typically presents between age 20 and 40 years with bilateral foot drop caused by anterior tibial[...]Article
Article
Article
Vanherpe P ; Fieuws S ; D'Hondt A ; Bleyenheuft C ; Demaerel P ; De Bleecker J ; van den Bergh P ; Baets J ; Remiche G ; Verhoeven K ; Delstanche S ; Toussaint M ; Buyse B ; Van Damme P ; Depuydt CE ; Claeys KG | 04/2020Article
Schoser B | 19/03/2020Initial Posting: September 21, 2006; Last Update: March 19, 2020. Clinical characteristics. Myotonic dystrophy type 2 (DM2) is characterized by myotonia and muscle dysfunction (proximal and axial weakness, myalgia, and stiffness), and less[...]Article
Kooi-van Es M ; Erasmus CE ; de Swart BJM ; Voet NBM ; van der Wees PJ ; De Groot IJM ; van den Engel-Hoek L | Netherlands | 03/2020Article
Abrams CK | 20/02/2020Initial Posting: June 18, 1998; Last Update: February 20, 2020. Clinical characteristics. GJB1 disorders are typically characterized by peripheral motor and sensory neuropathy with or without fixed CNS abnormalities and/or acute, self-limite[...]Article
Rosenberg H ; Sambuughin N ; Riazi S ; Dirksen R | 16/01/2020Initial Posting: December 19, 2003; Last Update: January 16, 2020. Clinical characteristics. Malignant hyperthermia susceptibility (MHS) is a pharmacogenetic disorder of skeletal muscle calcium regulation associated with uncontrolled skeleta[...]